Download PDF
Thromb Haemost 1998; 79(01): 195-201
DOI: 10.1055/s-0037-1614239
Review Article
Schattauer GmbH

Thrombopoietin Activates Human Platelets and Induces Tyrosine Phosphorylation of p80/85 Cortactin

Michaëla Fontenay-Roupie
1   From the Laboratoire d’Hématologie, Hôpital Cochin, Paris
2   From the INSERM U363, ICGM, Université Paris V, Hôpital Cochin, Paris
,
Guillaume Huret
1   From the Laboratoire d’Hématologie, Hôpital Cochin, Paris
,
Jean-Pierre Loza
1   From the Laboratoire d’Hématologie, Hôpital Cochin, Paris
,
Raphaël Adda
1   From the Laboratoire d’Hématologie, Hôpital Cochin, Paris
,
Josiane Melle
1   From the Laboratoire d’Hématologie, Hôpital Cochin, Paris
,
Jacques Maclouf
3   From the INSERM U348, Institut Fédératif de Recherche Circulation, Hôpital Lariboisière, Paris, France
,
François Dreyfus
1   From the Laboratoire d’Hématologie, Hôpital Cochin, Paris
2   From the INSERM U363, ICGM, Université Paris V, Hôpital Cochin, Paris
,
Sylviane Lévy-Toledano
3   From the INSERM U348, Institut Fédératif de Recherche Circulation, Hôpital Lariboisière, Paris, France
› Author Affiliations
Further Information

Publication History

Received 07 October 1996

Accepted after resubmission 13 August 1997

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

The mechanism of human platelet activation by thrombopoietin (TPO) was investigated in vitro. We found that rHuTPO stimulated thromboxane A2 formation and serotonin secretion, despite the absence of shape change and aggregation. Blockade of the arachidonic acid pathway did not inhibit rHuTPO-induced platelet secretion. rHuTPO stimulated the tyrosine phosphorylation of 64, 80/85, 95, 130 and 140 kDa proteins, but phosphoproteins of 100-105 and 125 kDa obtained when platelets aggregated in the presence of thrombin were absent. rHuTPO stimulated and potentiated the thrombin-induced tyrosine phosphorylation of a 80 kDa protein identified as the cortical actin-associated protein, p80/85 cortactin. When platelets were aggregated in the presence of rHuTPO and fibrinogen, cortactin phosphorylation was enhanced as compared to rHuTPO alone. Treatment with RGDS or cytochalasin D respectively reduced or abolished cortactin tyrosine phosphorylation. This confirms the existence of fibrinogen binding-dependent and independent pools of phosphorylated cortactin, both requiring intact actin polymerization. Cytoskeleton-binding proteins may be implicated in in vitro platelet activation by rHuTPO.

 

  • References

  • 1 de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Lolberg Jr LA, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature (London) 1994; 369: 533-8.
    CrossrefPubMedGoogle Scholar
  • 2 Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Helpel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O’Hara PJ, Roth GJ, Foster DC. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature (London) 1994; 369: 565-8.
    CrossrefPubMedGoogle Scholar
  • 3 Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 1994; 77: 1117-24.
    CrossrefPubMedGoogle Scholar
  • 4 Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papaynnopoulou T, Foster DC. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature (London) 1994; 369: 568-71.
    CrossrefPubMedGoogle Scholar
  • 5 Sohma Y, Akahori H, Seki N, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994; 353: 57-61.
    CrossrefPubMedGoogle Scholar
  • 6 Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature (London). 1994; 369: 571-4.
    CrossrefPubMedGoogle Scholar
  • 7 Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W. The mpl receptor is expressed in the megakaryocyte lineage from late progenitors to platelets. Blood 1995; 85: 391-401.
    PubMedGoogle Scholar
  • 8 Choi E, Hokom M, Bartley T, Li YS, Ohashi H, Kato T, Nichol JL, Skrine J, Knudten A, Chen J, Hornkohl A, Grampp G, Sleeman L, Cole S, Trail G, Hunt P. Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells 1995; 13: 317-28.
    CrossrefPubMedGoogle Scholar
  • 9 Montrucchio G, Brizzi MF, Calosso G, Marengo S, Pegoraro L, Camussi G. Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood 1996; 87: 2762-8.
    PubMedGoogle Scholar
  • 10 Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J. Regulation of platelet activation in vitro by the c-mpl ligand, thrombopoietin. Blood 1995; 86: 4054-60.
    PubMedGoogle Scholar
  • 11 Ezumi Y, Takayama H, Okuma M. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2 and STAT3 and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett 1995; 374: 48-52.
    CrossrefPubMedGoogle Scholar
  • 12 Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T, Abe T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 1995; 74: 1541-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Drachman JG, Griffin JD, Kaushansky K. The c-mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc and c-mpl. J Biol Chem 1995; 270: 4979-83.
    CrossrefPubMedGoogle Scholar
  • 14 Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol 1995; 23: 1040-8.
    PubMedGoogle Scholar
  • 15 Rodriguez-Linares B, Watson SP. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J 1996; 316: 93-8.
    CrossrefPubMedGoogle Scholar
  • 16 Miyakawa Y, Oda A, Drucker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995; 86: 23-7.
    PubMedGoogle Scholar
  • 17 Pallard C, Gouilleux F, Benit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 1995; 14: 2847-58.
    PubMedGoogle Scholar
  • 18 Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y. Thrombopoietin induces tyrosine phosphoryltaion of Stat3 and Stat5 in human blood platelets. Blood 1996; 87: 439-45.
    PubMedGoogle Scholar
  • 19 Wu H, Parsons JT. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993; 120: 1417-26.
    CrossrefPubMedGoogle Scholar
  • 20 Rendu F, Marche P, Maclouf J, Girard A, Levy-Toledano S. Triphosphoinositide breakdown and dense body release as the earliest events in thrombin-induced activation of human platelets. Biochem Biophys Res Commun 1983; 116: 513-8.
    CrossrefPubMedGoogle Scholar
  • 21 Pradelles P, Grassi J, Maclouf J. Enzyme immunoassay of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Annal Chem 1985; 57: 1170-3.
    CrossrefPubMedGoogle Scholar
  • 22 Colman RW, Figures WR, Scearce LM, Stimpler AM, Zhou F, Rao AK. Inhibition of collagen-induced platelet activation by 5’-pfluorosulfonylbenzoyladenosine: Evidence for an ADP requirement and synergistic influence of prostaglandin endoperoxides. Blood 1986; 68: 563-71.
    PubMedGoogle Scholar
  • 23 Worthington RE, Carroll RC, Boucheix C. Platelet activation by CD9 monoclonal antibodies is mediated by the FcgRII receptor. Br J Haematol 1990; 74: 216-22.
    CrossrefPubMedGoogle Scholar
  • 24 Golden A, Nemeth SP, Brugge JS. Blood platelets express high level of the pp60c-src specific tyrosine kinase activity. Proc Natl Acad Sci (USA) 1986; 83: 852-6.
    CrossrefPubMedGoogle Scholar
  • 25 Golden A, Brugge JS. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc Natl Acad Sci (USA) 1989; 86: 901-4.
    CrossrefPubMedGoogle Scholar
  • 26 Nakamura SI, Yamamura H. Thrombin and collagen induce rapid phosphorylation of a common set of cellular proteins on tyrosine in human platelets. J Biol Chem 1989; 264: 7089-96.
    PubMedGoogle Scholar
  • 27 Golden A, Brugge JS, Shattil SJ. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. J Cell Biol 1990; 111: 3117-27.
    CrossrefPubMedGoogle Scholar
  • 28 Huang M-M, Lipfert L, Cunningham M, Brugge JS, Ginsberg MH, Shattil SJ. Adhesive ligand binding to integrin αIIbß3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK . J Cell Biol 1993; 122: 473-83.
    CrossrefPubMedGoogle Scholar
  • 29 Mitchell CA, Bennett Jefferson A, Bejeck BE, Brugge JS, Deuel TF, Majerus PW. Thrombin-stimulated immunoprecipitation of phosphatidylinositol 3-kinase from human platelets. Proc Natl Acad Sci (USA) 1990; 87: 9396-9.
    CrossrefPubMedGoogle Scholar
  • 30 Rodriguez-Linares B, Watson SP. Phosphorylation of JAK2 in thrombin-stimulated human platelets. FEBS Lett 1994; 352: 335-43.
    CrossrefPubMedGoogle Scholar
  • 31 Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995; 270: 27395-401.
    CrossrefPubMedGoogle Scholar
  • 32 Miyakawa Y, Oda A, Druker BJ, Ozaki K, Handa M, Ohashi H, Ikeda Y. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Blood 1997; 89: 2789-98.
    PubMedGoogle Scholar
  • 33 Zauli G, Bassini A, Vitale M, Gibellini D, Celeghini C, Caramelli E, Pierpaoli S, Guidotti L, Capitani S. Thrombopoietin enhances the αIIbβ3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. Blood 1997; 89: 883-95.
    PubMedGoogle Scholar
  • 34 Ozawa K, Kashiwada K, Takahashi M, Sobue K. Translocation of cortactin (p80/85) to the actin-based cytoskeleton during thrombin receptor-mediated platelet activation. Exp Cell Res 1995; 221: 197-204.
    CrossrefPubMedGoogle Scholar
  • 35 Rosa JP, Artçanuthurry V, Grelac F, Maclouf J, Caen JP, Lévy-Toledano S. Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets. Evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin αIIbβ3 . Blood 1997; 89: 4385-92.
    PubMedGoogle Scholar
  • 36 Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT. Identification of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 1991; 11: 5113-24.
    CrossrefPubMedGoogle Scholar
  • 37 Lefebvre P, White JG, Krumwiede MD, Cohen I. Role of actin in platelet function. Eur J Cell Biol 1993; 62: 194-204.
    PubMedGoogle Scholar
  • 38 Fox JEB, Shattil SJ, Kinlough-Rathbone RL, Richardson M, Packham M, Sanan DA. The platelet cytoskeleton stabilizes the interaction between αIIbβ3 and its ligand and induces selective movments of ligand-occupied integrin. J Biol Chem 1996; 271: 7004-11.
    CrossrefPubMedGoogle Scholar
  • 39 Oda A, Ozaki K, Druker BJ, Miyakawa Y, Miyazaki H, Handa M, Morita H, Ohashi H, Ikeda Y. p120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin. Blood 1996; 88: 1330-8.
    PubMedGoogle Scholar
  • 40 Wong S, Reynolds AB, Papkoff J. Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein. Oncogene 1992; 7: 2407-15.
    PubMedGoogle Scholar
  • 41 Maruyama S, Kurosaki T, Sada K, Yamanashi Y, Yamamoto T, Yamamura H. Physical and functional association of cortactin with Syk in human leukemic cell line K562. J Biol Chem 1996; 271: 6631-5.
    CrossrefPubMedGoogle Scholar
  • 42 Zhan X, Haudenschild CC, Ni Y, Smith E, Huang C. Upregulation of cortactin expression during the maturation of megakaryocytes. Blood 1997; 89: 457-64.
    PubMedGoogle Scholar